TLX

3.03%

$19.18

TELIX PHARMACEUTICALS LIMITED

Market Cap $6.418B Add to my watchlist

Healthcare Biotechnology

Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company. The... Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company. The Company is focused on the development and commercialization of diagnostic and therapeutic radiopharmaceuticals and associated medical devices. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its core pipeline is focused on prostate cancer, renal cancer, brain cancer (glioma) and rare diseases (hematologic cancers and bone marrow conditioning). Its pipelines include TLX591, TLX592 (alpha-RADmAb), TLX591-CDx, TLX250, TLX250-CDx, TLX101, TLX101-CDx, TLX300, TLX300-CDx, TLX66, and TLX66-CDx. TLX591 is a radio antibody-drug conjugate (rADC) directed at prostate-specific membrane antigen (PSMA). Its product QUANTM Irradiation System (QIS), enables production of important medical isotopes such as gallium-68 (68Ga), zirconium-89 (89Zr), technetium-99m (99mTc) and copper-64 (64Cu).More

BlinkLab Limited (ASX: BB1) is a trailblazer in digital healthcare, leveraging AI and machine learning in mobile applications to revolutioniSe neurodevelopmental condition diagnosis like ASD and ADHD. Born from extensive research at Princeton University,...

Latest Threads

Tag

Subject

TLX Biotech

Understanding Telix

21 22 23

13:41

1.3K

650K

13:41

Last post Neutralone

1.3K

650K

TLX

Short Term trading, analysis and TLX noise - No investors keep out

9 10 11

23/08/24

630

226K

23/08/24

Last post flotsam222

630

226K

TLX

Ann: Telix 1H 2024 Results Presentation

23/08/24

16K

23/08/24

Last post gingerclam

16K

TLX

Ann: Telix 2024 Half-Year Results Investor Webcast Notification

23/08/24

6.2K

23/08/24

Last post spnc

6.2K

TLX

Ann: Telix 1H 2024 Results Release

23/08/24

2.1K

23/08/24

Last post Prisoner24601

2.1K

TLX

Ann: Telix 1H 2024 Appendix 4D and Interim Report

23/08/24

2.1K

23/08/24

Last post mnbvcxz12345

2.1K

TLX

Ann: Telix Successfully Prices A$650M Convertible Bonds

22/08/24

33K

22/08/24

Last post spnc

33K

TLX

Ann: Ceasing to be a substantial holder

22/08/24

370

22/08/24

Last post

ASX News

370

See All Discussions

Timeline

Ceasing to be a substantial holder
22 Aug 18:10	Share

Securities Dealing Policy - Updated
22 Aug 17:23	Share

Telix 1H 2024 Results Presentation
22 Aug 16:42	Share

Telix 1H 2024 Results Release
22 Aug 16:41	Share

Telix 1H 2024 Appendix 4D and Interim Report
22 Aug 16:40	Share

Becoming a substantial holder
21 Aug 18:07	Share

Ceasing to be a substantial holder
14 Aug 14:47	Share

Telix 2024 Half-Year Results Investor Webcast Notification
13 Aug 08:15	Share

Becoming a substantial holder
13 Aug 08:10	Share

Ceasing to be a substantial holder
07 Aug 17:38	Share

Ceasing to be a substantial holder
05 Aug 08:15	Share

Investor Conference Call - TLX250-CDx BLA Filing Update
31 Jul 09:57	Share

BLA Filing Update for Renal Cancer Imaging Agent TLX250-CDx
31 Jul 09:56	Share

Appendix 3G
30 Jul 13:38	Share

Telix Completes A$650 Million of Convertible Bonds
30 Jul 13:02	Share

Convertible Bond Cleansing Notice
30 Jul 08:32	Share

Becoming a substantial holder
29 Jul 08:12	Share

Becoming a substantial holder
26 Jul 17:07	Share

FDA Accepts Telix NDA for New Prostate Cancer Imaging Agent
24 Jul 09:28	Share

Appendix 3B
24 Jul 09:04	Share

Telix Successfully Prices A$650M Convertible Bonds
24 Jul 08:57	Share

Telix Investor Presentation July 2024
23 Jul 16:59	Share

Telix Announces A$600 Million Convertible Bonds Offering
23 Jul 16:57	Share

Telix Q2 2024 Revenue/Business Highlights, Guidance Upgrade
18 Jul 08:32	Share

CMS proposes payment improvement for radiopharma diagnostics
11 Jul 09:49	Share

Notification of cessation of securities - TLX
10 Jul 08:23	Share

Cleansing Notice
04 Jul 08:26	Share

Application for quotation of securities - TLX
04 Jul 08:26	Share

Ceasing to be a substantial holder
03 Jul 13:20	Share

Ceasing to be a substantial holder from MUFG
03 Jul 12:37	Share

View More

(20min delay)
Last $19.18		Change -0.600(3.03%)		Mkt cap ! $6.418B

Open	High	Low	Value	Volume
$18.90	$19.21	$18.04	$51.74M	2.756M

Buyers (Bids)

No.	Vol.	Price($)
2	710	$19.15

Sellers (Offers)

Price($)	Vol.	No.
$19.20	7058	2

View Market Depth

No.	Vol.	Price($)
2	710	19.150
1	95	19.000
1	1000	18.810
1	300	18.800
1	330	18.760

Price($)	Vol.	No.
19.200	500	1
19.220	520	1
19.240	1500	1
19.250	2000	1
19.260	1000	1

Last trade - 16.10pm 23/08/2024 (20 minute delay)


Last $19.11		Change -0.600 ( 3.41 %)
Open	High	Low	Volume
$18.87	$19.21	$18.04	542421
Last updated 15.59pm 23/08/2024 ?

TLX (ASX) Chart

TELIX PHARMACEUTICALS LIMITED

Latest Threads

Timeline

Featured News

Latest Articles

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

Telix has announced its prostate cancer imaging drug Illuccix won't be negatively impacted by proposed changes to the US medicare system.

Telix dips as pharma giant abandons US IPO for NASDAQ listing – despite record run

International plans for Telix – proudly boasting its intentions to list on the NASDAQ for a while now – have come to an anticlimactic end.

Telix kicks off $300M NASDAQ IPO offer, backed by Morgan Stanley

Morgan Stanley and Jefferies are among the managers overseeing Telix Pharma's (ASX:TLX) freshly commenced US IPO process.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News